Literature DB >> 28279464

Minimally Invasive Surgery: The Emerging Role in Gastric Cancer.

Michael R Cassidy1, Sepideh Gholami1, Vivian E Strong2.   

Abstract

Minimally invasive surgical techniques are an emerging option in the staging and management of gastric cancer in the United States and elsewhere. Although much of the current knowledge about these approaches and their outcomes has been generated in Eastern countries, experience in the United States is growing. This article discusses both laparoscopic and robotic approaches to gastric cancer management. Important aspects of patient selection are emphasized. Surgical and oncologic outcomes are presented and compared with traditional open gastrectomy. Technical considerations are discussed along with comments on the learning curve to achieve proficiency in each approach.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gastric cancer; Laparoscopic gastrectomy; Minimally invasive gastrectomy; Robotic gastrectomy

Mesh:

Year:  2017        PMID: 28279464     DOI: 10.1016/j.soc.2016.10.001

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  3 in total

Review 1.  Minimally invasive surgery for gastric cancer in UK: current status and future perspectives.

Authors:  Muhammad Shafique Sajid; Madhusoodhana Hebbar; Mazin E Sayegh
Journal:  Transl Gastroenterol Hepatol       Date:  2017-05-09

2.  Utilization of Minimally Invasive Surgery and Its Association with Chemotherapy for Locally Advanced Gastric Cancer.

Authors:  Rhami Khorfan; Cary Jo R Schlick; Anthony D Yang; David D Odell; David J Bentrem; Ryan P Merkow
Journal:  J Gastrointest Surg       Date:  2019-11-20       Impact factor: 3.452

3.  Minimally Invasive Pancreatoduodenectomy: Contemporary Practice, Evidence, and Knowledge Gaps.

Authors:  Jacob Ghotbi; Mushegh Sahakyan; Kjetil Søreide; Åsmund Avdem Fretland; Bård Røsok; Tore Tholfsen; Anne Waage; Bjørn Edwin; Knut Jørgen Labori; Sheraz Yaqub; Dyre Kleive
Journal:  Oncol Ther       Date:  2022-07-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.